DarioHealth Corp
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
DRIO$2.06-13.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Item No. · Description · Page | ||||
|---|---|---|---|---|
| Cautionary Note Regarding Forward-Looking Statements | 3 | |||
| PART I · | ||||
| Item 1. | Business | 5 | ||
| Item 1A. | Risk Factors | 56 | ||
| Item 1B. | Unresolved Staff Comments | 81 | ||
| Item 1C. | | Cybersecurity | | 82 |
| Item 2. | Properties | 82 | ||
| Item 3. | Legal Proceedings | 82 | ||
| Item 4. | Mine Safety Disclosures | 82 | ||
| PART II · | ||||
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 83 | ||
| Item 6. | [Reserved] | 86 | ||
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 86 | ||
| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk | 97 | ||
| Item 8. | Financial Statements and Supplementary Data | 98 | ||
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 98 | ||
| Item 9A. | Controls and Procedures | 98 | ||
| Item 9B. | Other Information | 99 | ||
| Item 9C | | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | | 99 |
| PART III · | ||||
| Item 10. | Directors, Executive Officers and Corporate Governance | 99 | ||
| Item 11. | Executive Compensation | 105 | ||
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 110 | ||
| Item 13. | Certain Relationships and Related Transactions, and Director Independence | 112 | ||
| Item 14. | Principal Accounting Fees and Services | 113 | ||
| PART IV · | ||||
| | ||||
| Item 15. | Exhibits and Financial Statement Schedules | 114 | ||
| Signatures | 118 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.